The annual meeting of the American Society of Hematology (ASH) brings together leaders from around the world who treat people with blood cancers and other blood disorders. Doctors and researchers from Memorial Sloan Kettering presented their research at the meeting,held this year in Orlando. Below are some highlights from the past few days.
Chimeric antigen receptor (CAR) T cell therapies have been in the spotlight at the ASH meeting. Many scientists in the field are excited by the prospect of using the genome-editing tool CRISPR to engineer more-potent CAR T cells.
At MSK, researchers Michel Sadelain, Renier Brentjens, and Isabelle Rivire and their colleagues are at the forefront of CAR T science. Just last year, the team published results from the longest-running clinical trial of CAR therapy, showing which patients benefitted most. This year at ASH, another member of that team, MSK medical oncologist Jae Park, presented the results of a retrospective study that provides clues into who may benefit most from a stem cell transplant following CAR therapy.
A stem cell transplantreplaces a persons blood-forming stem cells with those from a donor. It can be a cure for some people with cancer, yet it comes with serious potential risks, such as life-threatening infections and graft-versus-host disease. Previous research from Dr. Park and his colleagues had suggested that there was no clear survival advantage to a stem cell transplant in adults with acute lymphoblastic leukemia (ALL) who were treated with CAR T cells. But the scientists were curious to find out if a group of patients would benefit from the procedure.
Of 53 adults with ALL who received CAR T cells at MSK, 16 of those who had a complete response to the CAR therapy went on to have a stem cell transplant. Dr. Park and his colleagues looked for correlations between how well these patients did and several variables: age, a prior stem cell transplant, the presence of the Philadelphia chromosome, the amount of disease measurable at the time of the CAR therapy, the severity of cytokine release syndrome, and neurotoxicity.
The only variables that seemed to make a difference were age and neurotoxicity. Specifically, being younger and having no severe neurotoxicity during CAR therapy were associated with improved overall survival following a stem cell transplant. Dr. Park cautioned that the small size of the study limits drawing firm conclusions. Nevertheless, the results point to a group of people for whom the potential benefits of a stem cell transplant may outweigh the risks. Further research is needed.
MSK hematologist-oncologist Anthony Mato presented the results of several studies aimed at improving care for people with chronic lymphocytic leukemia (CLL). One study dealt with identifying the best treatment options for people with CLL who have had to stop taking the targeted drug venetoclax (Venclexta). Dr. Mato and colleagues conducted a retrospective study of 326 people with CLL from around the world who received venetoclax and then switched to another drug.
They looked at how well these people did on various treatments specifically BTK inhibitors, PI3K inhibitors, CAR T therapy, and stem cell transplantation. Of these, they found that BTK inhibitors were an effective post-venetoclax treatment, provided the patients had not yet received BTK inhibitors or had not developed resistance to these drugs. They also found that a stem cell transplant was a good option that provided lasting benefits.
Together, these studies show the progress we at MSK are making in developing much-needed therapies for people with CLL.
In a second presentation, Dr. Mato discussed the results of a first-in-human trial of a BTK inhibitor called LOXO-305. This targeted drug works differently than existing BTK inhibitors. The trial, which enrolled 13 people, showed that LOXO-305 was safe. It also provided proof of concept that this approach may be effective at helping people with CLL and other B cell cancers, including those who have developed resistance to existing BTK inhibitors.
Finally, Dr. Mato discussed results from a study that tested a combination of targeted drugs given at lower dosages to people with CLL. Combination approaches have the potential to preempt the emergence of drug resistance but are often too toxic when each drug is given at full strength.
The phase I study tested a lower-dose combination of the BTK inhibitor everolimus (Afinitor, Zortress) and pomalidomide (Pomalyst). It included 33 people with CLL and lymphoma who lacked an approved treatment option. Dr. Mato and his colleagues found that this combination, named DTRM-555, was generally safe and showed signs of effectiveness in several people. A phase II study of the combination is underway.
Together, these studies show the progress we at MSK are making in developing much-needed therapies for people with CLL, Dr. Mato says.
Blood clots are a life-threatening side effect in people being treated for cancer. Known risk factors for blood clots include cancer type and stage, obesity, blood cell counts, and treatment with chemotherapy. However, it is still difficult for doctors to predict the risk of blood clots in individual people.
To find out if a tumors molecular profile could predict the risk of blood clots, MSK hematologist Simon Mantha and colleagues conducted a study in which they analyzed tumor DNA sequences for 341 genes in 11,695 people with cancer.
As Dr. Mantha presented at the ASH meeting, the scientists found that mutations in several genes STK11, MET, KEAP1, CTNNB1, and KRAS increase the risk of blood clots in people with cancer.
Dr. Mantha hopes these findings will ultimately translate into better methods to predict who is most at risk for this dangerous complication.
Read about other MSK science at ASH hereand here.
- Learning to be relentless - The Daily Republic - January 19th, 2020
- Here's Why Stemline Therapeutics Dropped Today - Motley Fool - January 19th, 2020
- Medics key to spotting signs of child abuse, Abu Dhabi conference hears - The National - January 19th, 2020
- Smart Group & A4M Concluded their First India Conference 2020 - NewsPatrolling - January 19th, 2020
- 'Comfort' or con? Despite money, education, well-off Filipinos turning to questionable treatments - Coconuts - January 13th, 2020
- Doctor's Hospital focused on incorporation of AI and machine learning - EyeWitness News - January 13th, 2020
- Viewpoints: Medicaid Expansion Reveals How Liberal Policies Make For Good Politics; Hey, Congress, What's The Hold Up With Surprise Medical Bills? -... - January 13th, 2020
- White blood cells: Function, ranges, types, and more - Medical News Today - January 10th, 2020
- Tacitus Therapeutics Launches in Collaboration with Mount Sinai to Develop Stem Cell Therapies for Life-Threatening Diseases - PRNewswire - January 10th, 2020
- Tip Sheet: Mesh loaded with T cells shrinks tumors; second dose of CAR-T cells shows potential; and gene-edited cells stay safe as immunotherapy... - January 10th, 2020
- 3D-printed Organs Give Hope to Transplant Patients Now. Powered by - Now. Powered by Northrop Grumman. - January 10th, 2020
- Seattle Childrens faces widening array of lawsuits over fatal mold infections - Seattle Times - January 10th, 2020
- Landisa: My cancer can relapse but here's why I am not afraid of it any longer - News24 - January 10th, 2020
- 'You wouldn't give it to your worst enemy': what it's like to live with Lyme disease - Telegraph.co.uk - January 10th, 2020
- The 'supercells' that cured an infant's grave genetic illness - Japan Today - January 10th, 2020
- Edited Transcript of BYSI.OQ earnings conference call or presentation 18-Dec-19 1:00pm GMT - Yahoo Finance - January 8th, 2020
- How These Practitioners Can Help with New Year, New You Goals - Milwaukee Magazine - January 7th, 2020
- Summerside gym needs donations for three-year-old boy with cancerous brain tumors - The Journal Pioneer - January 7th, 2020
- The woman who spent 7 years in and out of hospital battling rare condition some doctors had never seen - Leicestershire Live - January 7th, 2020
- West Norwood girl, 3, dies in her parents' arms after brave battle with leukaemia - MyLondon - January 7th, 2020
- DuPont, C8 Contamination And The Community Left To Grapple With The Consequences - WVXU - January 7th, 2020
- What are the odds? Stem cell recipient learns her donor is also in Ottawa - Ottawa Citizen - January 3rd, 2020
- Understanding the Key Aspects of a Multiple Myeloma Diagnosis - Curetoday.com - January 3rd, 2020
- The 'supercells' that cured an infant's grave genetic illness - FRANCE 24 - January 3rd, 2020
- How supercells cured an infants grave genetic illness - Raw Story - January 3rd, 2020
- Firm adds a new wrinkle to anti-aging products - Williamson Daily News - January 3rd, 2020
- First Edition: January 3, 2020 - Kaiser Health News - January 3rd, 2020
- Finn the Fabulous to ring treatment bell after leaving hospital - expressandstar.com - January 3rd, 2020
- Conway supports man fighting rare double diagnosis of MS, ALS - THV11.com KTHV - January 1st, 2020
- Predicting shifts in technology and science can be tricky, but here's what could happen in 2020 - inews - January 1st, 2020
- None of these four beaming children would be alive today if a stranger had not given blood - The Sun - January 1st, 2020
- On the Road: A year to remember - WCBI - January 1st, 2020
- 2019: the year gene therapy came of age - Breitbart - January 1st, 2020
- The health stories we won't forget and what 2020 holds - nation.co.ke - January 1st, 2020
- Chinese scientist who claimed he genetically edited babies gets prison term - Los Angeles Times - December 30th, 2019
- Year in Review: Gene Therapy Technology and a Milestone 2019 for Medical Research - News18 - December 30th, 2019
- Finding Joy While Struggling With Infertility Over The Holidays - SheKnows - December 25th, 2019
- The reporter driven to do 'whatever it takes' to conquer cancer and return to the press box - The Athletic - December 25th, 2019
- A blood cancer diagnosis helped me find true happiness - The Guardian - December 25th, 2019
- Michael Schumacher health: Doctor reveals truth about Schumi as Lewis Hamilton is catching up fast to break F1 legend's record - EconoTimes - December 25th, 2019
- Mother and son, together, cope with autism and multiple sclerosis - MLive.com - December 25th, 2019
- Local firm adds a new wrinkle to anti-aging products - Williamson Daily News - December 25th, 2019
- Miracle recovery of rider and her horse after severe injuries - Yorkshire Post - December 25th, 2019
- Before the 90 Days Stephanie is YouTuber Stepanka. Is she really ill & bi? - Starcasm - December 21st, 2019
- Stem Cell Therapy Treatment - Melbourne Stem Cell Centre - December 10th, 2019
- U.S. Stem Cell Training | Regenerative Medicine Training ... - December 10th, 2019
- Injectables Are the Future of K-Beauty Trends in America - Yahoo Lifestyle - December 10th, 2019
- Orgenesis and Theracell to Launch Point of Care Cell and Gene Therapy Centers within HYGEIA Group's Hospital Network in Greece - GlobeNewswire - December 10th, 2019
- 2019: The year gene therapy came of age - Jamaica Observer - December 10th, 2019
- Ethan's Army gets a boost - Brockville Recorder and Times - December 10th, 2019
- BREAKING: Baby body parts criminal trial to proceed against Daleiden with possible jail time - Lifesite - December 7th, 2019
- 'I was given a terminal diagnosis and then a new therapy cured my leukaemia' - The Telegraph - December 5th, 2019
- Stem Cell Therapy Market Robust pace of Industry during 2017-2025 - News Description - December 5th, 2019
- A #ReUp of 2019: The year when gene therapy, DNA modifications came of age & saved lives - Economic Times - December 5th, 2019
- 100 greatest innovations of 2019: Best of What's New - Popular Science - December 3rd, 2019
- Susan J. Demas: Right-wing lies on abortion paved the way for Trump - Michigan Advance - December 3rd, 2019
- Alum's New Book Recounts His Fight to Help First Responders Sickened after 9/11 - BU Today - December 3rd, 2019
- Quinn Waters: Weymouth, Massachusetts three-year-old is seeing the world for himself - CBS News - December 2nd, 2019
- 'We didn't worry when 2-year-old refused to use potty - then her lips went blue' - Mirror Online - December 2nd, 2019
- Upstate SC toddler survives rare cancer and the risky procedure used to treat it - Greenville News - December 2nd, 2019
- 13 YEAR OLD BOY WHO SURVIVED RARE CHILDHOOD CANCER TWICE SUPPORTS NEW FUNDRAISING CAMPAIGN - MENAFN.COM - December 2nd, 2019
- Heartbreaking photograph shows the reality of childhood cancer - Yahoo News - December 2nd, 2019
- Family releases photo sharing the reality of childhood cancer - NEWS.com.au - December 2nd, 2019
- "For the first time in 25 years this means hope" - Leeds family fundraising for life-changing MS treatment - Yorkshire Post - December 2nd, 2019
- Calgary MP won't give up effort to add donor consent option to tax forms - Calgary Herald - December 2nd, 2019
- Every 13th man has a hair transplant according to Bookimed study - PR Web - November 29th, 2019
- Heartbreaking photograph shows the reality of childhood cancer - Yahoo Sports - November 29th, 2019
- 253 miles in 4 hours: A Syracuse mans race for a lung transplant, and the angel who helped him - syracuse.com - November 29th, 2019
- Exploring the Future of Prostate Cancer with City of Hope - Curetoday.com - November 29th, 2019
- Imani Barbarin Coins #PatientsAreNotFaking to Fight Back Against Negative Patient Stereotypes - The Mary Sue - November 29th, 2019
- South Carolina toddler survives rare cancer and the risky procedure used to treat it - USA TODAY - November 29th, 2019
- Mum shares heart-wrenching photos to show the 'reality of childhood cancer' - Mirror Online - November 29th, 2019
- Diabetic foot wounds kill millions, but high-tech solutions and teamwork are making a difference - The Conversation US - November 29th, 2019
- Toddler Bravely Cheats Death After He Survived Rare Cancer And Its Treatment - The Digital Weekly - November 29th, 2019
- 'My daughter's death took me to the darkest place, but I've learned it's possible to come back' - Telegraph.co.uk - November 29th, 2019
- Ausman family thankful for recoveries, support from family and community - Chippewa Herald - November 29th, 2019
- 2nd Edition Africa Healthcare Extension Summit And Africa Women's Health Summit Starts Today In Nairobi - Africa.com - November 29th, 2019
- How the Packers' Za'Darius Smith brought joy and awareness to one woman's cancer fight - The Athletic - November 29th, 2019
- Thalassemia Treatment Market With Top Countries Data : Analysis and by Recent Trends and Regional Growth Overview Forecast 2026 - News Description - November 29th, 2019
- The ART of Having Children - Vision Insights and New Horizons - November 24th, 2019